OXFORD BIODYNAMICS PLC Logo

OXFORD BIODYNAMICS PLC

OBD | IL

Overview

Corporate Details

ISIN(s):
GB00BD5H8572 (+2 more)
LEI:
2138005Y1TK258O5U928
Country:
United Kingdom
Address:
3140 ROWAN PLACE, JOHN SMITH DRIVE, OX4 2WB OXFORD
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Oxford BioDynamics PLC is a global biotechnology company advancing personalized healthcare by developing and commercializing precision medicine tests for life-changing diseases. The company's core technology is the proprietary EpiSwitch® platform, which analyzes 3D genome regulation to discover and develop novel epigenetic biomarkers. Its primary products include the EpiSwitch® PSE, a blood test that detects the likelihood of prostate cancer with high accuracy to reduce unnecessary biopsies, and the EpiSwitch® CiRT, a test to predict a patient's therapeutic response to Immune Checkpoint Inhibitor cancer therapies. Oxford BioDynamics focuses on translating genomic data into clinically actionable insights to improve diagnosis and treatment guidance.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for OXFORD BIODYNAMICS PLC. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-13 08:00
Regulatory News Service
Collaboration with Google Cloud
English 12.0 KB
2025-07-18 16:11
Major Shareholding Notification
Holding(s) in Company
English 21.9 KB
2025-07-17 08:01
Report Publication Announcement
GenomeWeb to host joint Agilent/OBD presentation
English 18.3 KB
2025-07-17 08:00
Major Shareholding Notification
Holding(s) in Company
English 23.3 KB
2025-07-15 18:20
Major Shareholding Notification
Holding(s) in Company
English 23.2 KB
2025-07-15 08:00
Regulatory News Service
Pfizer study on EpiSwitch biomarkers
English 19.7 KB
2025-07-01 16:00
Major Shareholding Notification
Holding(s) in Company
English 23.3 KB
2025-06-30 08:00
Earnings Release
Interim Results
English 706.2 KB
2025-06-27 14:30
Major Shareholding Notification
Holding(s) in Company
English 23.3 KB
2025-03-28 11:35
Post-Annual General Meeting Information
Result of AGM
English 12.3 KB
2025-03-17 08:00
Board/Management Information
Board Changes
English 18.2 KB
2025-03-14 18:25
Major Shareholding Notification
Holding(s) in Company
English 23.2 KB
2025-03-13 08:00
Regulatory News Service
Expansion of OBD/Bupa UK insurance partnership
English 26.1 KB
2025-03-05 17:00
Report Publication Announcement
Publication of 2024 Annual Report
English 13.7 KB
2025-03-03 08:00
Remuneration Information
PDMR Dealing / Grant of Share Options
English 67.5 KB

Automate Your Workflow. Get a real-time feed of all OXFORD BIODYNAMICS PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for OXFORD BIODYNAMICS PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo
Offers contract R&D, develops tech platforms, and invests in life sciences ventures.
Spain IKM
2cureX AB Logo
Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.
Sweden 2CUREX
4SC AG Logo
Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.
Sweden ABERA
ABIVAX Logo
Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.
France ABVX
Abliva Logo
A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.
Sweden ABLI
Achiko AG Logo
A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.
Switzerland ACHI
Acticor Biotech Logo
Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.
France ALACT
Active Biotech Logo
Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.
Sweden ACTI
Addex Therapeutics Ltd Logo
Develops oral small molecule drugs, allosteric modulators, for neurological disorders.
Switzerland ADXN